Clinical studies have shown that the level of ApoB/ApoA1 in gastric cancer patients is negatively correlated with the survival rate, while PDIA4 is positively correlated with the survival rate of gastric cancer patients (Ma et al., 2018). Here, APOA1 is linked to gastric cancer.